SHP2 inhibitors (Ubix Therapeutics/SK Biopharmaceuticals)

N/A

Report date: 2025/06/11 10:43:34
NME

Base Information

Drug NameSHP2 inhibitors (Ubix Therapeutics/SK Biopharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitorsAnticancer protein kinase inhibitors
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUbix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSK Biopharmaceuticals Co LtdUbix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A